[Ovid] Discordance Abounds in Minimum Clinically Important Differences in THA: A Systematic Review |
Reward10points
Best Answer
2024-4-20
|
| |
| |
10
Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events
10
PCSK9-directed therapies: an update
10
C-reactive protein, pharmacological treatments and diet: how to target your inflammatory burden
10
Bempedoic acid: new evidence and recommendations on use
10
The dysmorphic phenotype in vascular Ehlers Danlos syndrome
